Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim was to formulate practice guidelines for endocrine treatment of transsexual persons. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and the quality of evidence, which was low or very low. CONSENSUS PROCESS: Committees and members of The Endocrine Society, European Society of Endocrinology, European Society for Paediatric Endocrinology, Lawson Wilkins Pediatric Endocrine Society, and World Professional Association for Transgender Health commented on preliminary drafts of these guidelines. CONCLUSIONS: Transsexual persons seeking to develop the physical characteristics of the desired gender require a safe, effective hormone regimen that will 1) suppress endogenous hormone secretion determined by the person's genetic/biologic sex and 2) maintain sex hormone levels within the normal range for the person's desired gender. A mental health professional (MHP) must recommend endocrine treatment and participate in ongoing care throughout the endocrine transition and decision for surgical sex reassignment. The endocrinologist must confirm the diagnostic criteria the MHP used to make these recommendations. Because a diagnosis of transsexualism in a prepubertal child cannot be made with certainty, we do not recommend endocrine treatment of prepubertal children. We recommend treating transsexual adolescents (Tanner stage 2) by suppressing puberty with GnRH analogues until age 16 years old, after which cross-sex hormones may be given. We suggest suppressing endogenous sex hormones, maintaining physiologic levels of gender-appropriate sex hormones and monitoring for known risks in adult transsexual persons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
A Handbook of Child Psychology
(1932) · Nature · doi:10.1038/130331a0 · Cited by 10,101
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Tanner, J. M. (1978) · Medical Entomology and Zoology · Cited by 3,742
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Self-citation(2020) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,683
Cited by
Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., et al. (2012) · International Journal of Transgenderism · doi:10.1080/15532739.2011.700873 · Cited by 3,143
Self-citationStandards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,698
Self-citation(2012) · Choice Reviews Online · doi:10.5860/choice.49-2699 · Cited by 2,593
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01658 · Cited by 2,328
Self-citationYoung Adult Psychological Outcome After Puberty Suppression and Gender Reassignment
de Vries, A. L. C., McGuire, J. K., Steensma, T. D., Wagenaar, E. C. F., Doreleijers, T. A. H., & Cohen-Kettenis, P. T. (2014) · Pediatrics · doi:10.1542/peds.2013-2958 · Cited by 927
Self-citationBarriers to healthcare for transgender individuals
Safer, J. D., Coleman, E., Feldman, J., Garofalo, R., Hembree, W., Radix, A., & Sevelius, J. (2016) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000227 · Cited by 897
Self-citationThe mental health of transgender youth: Advances in understanding
Connolly, M. D., Zervos, M. J., Barone, C. J., Johnson, C. C., & Joseph, C. L. M. (2016) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.06.012 · Cited by 693
Puberty Suppression in Adolescents With Gender Identity Disorder: A Prospective Follow-Up Study
de Vries, A. L. C., Steensma, T. D., Doreleijers, T. A. H., & Cohen-Kettenis, P. T. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01943.x · Cited by 639
Self-citationA long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones
Asscheman, H., Giltay, E. J., Megens, J. A. J., de Ronde, W. (., van Trotsenburg, M. A. A., & Gooren, L. J. G. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1038 · Cited by 570
Self-citationTransgender Men Who Experienced Pregnancy After Female-to-Male Gender Transitioning
Light, A. D., Obedin-Maliver, J., Sevelius, J. M., & Kerns, J. L. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000540 · Cited by 553
Reed, G. M., Drescher, J., Krueger, R. B., Atalla, E., Cochran, S. D., First, M. B., Cohen‐Kettenis, P. T., Arango‐de Montis, I., Parish, S. J., Cottler, S., et al. (2016) · World Psychiatry · doi:10.1002/wps.20354 · Cited by 469
Self-citationRisk and Protective Factors in the Lives of Transgender/Gender Nonconforming Adolescents
Eisenberg, M. E., Gower, A. L., McMorris, B. J., Rider, G. N., Shea, G., & Coleman, E. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2017.04.014 · Cited by 463
Clinical management of gender dysphoria in children and adolescents: the dutch approach
de Vries, A. L. C., & Cohen-Kettenis, P. T. (2012) · Journal of Homosexuality · doi:10.1080/00918369.2012.653300 · Cited by 451
Self-citationChildren and Adolescents With Gender Identity Disorder Referred to a Pediatric Medical Center
Spack, N. P., Edwards-Leeper, L., Feldman, H. A., Leibowitz, S., Mandel, F., Diamond, D. A., & Vance, S. R. (2012) · Pediatrics · doi:10.1542/peds.2011-0907 · Cited by 426
Self-citationGlobal Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People
Poteat, T., Scheim, A., Xavier, J., Reisner, S., & Baral, S. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001087 · Cited by 393
Gender and Sex Differences in Adipose Tissue
Chang, E., Varghese, M., & Singer, K. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1031-3 · Cited by 382
Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People
Coleman, E. (2017) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-803506-1.00058-9 · Cited by 370
Olson, J., Schrager, S. M., Belzer, M., Simons, L. K., & Clark, L. F. (2015) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2015.04.027 · Cited by 367
Jaffee, K. D., Shires, D. A., & Stroumsa, D. (2016) · Medical Care · doi:10.1097/mlr.0000000000000583 · Cited by 368
The Health and Health Care of Lesbian, Gay, and Bisexual Adolescents
Coker, T. R., Austin, S. B., & Schuster, M. A. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103636 · Cited by 364
Youth and Caregiver Perspectives on Barriers to Gender-Affirming Health Care for Transgender Youth
Gridley, S. J., Crouch, J. M., Evans, Y., Eng, W., Antoon, E., Lyapustina, M., Schimmel-Bristow, A., Woodward, J., Dundon, K., Schaff, R., et al. (2016) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.03.017 · Cited by 345
Sexual differentiation of human behavior: Effects of prenatal and pubertal organizational hormones
Berenbaum, S. A., & Beltz, A. M. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.03.001 · Cited by 339
Reproductive wish in transsexual men
Wierckx, K., Van Caenegem, E., Pennings, G., Elaut, E., Dedecker, D., Van de Peer, F., Weyers, S., De Sutter, P., & T'Sjoen, G. (2012) · Human Reproduction · doi:10.1093/humrep/der406 · Cited by 336
Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual Persons
Wierckx, K., Mueller, S., Weyers, S., Van Caenegem, E., Roef, G., Heylens, G., & T’Sjoen, G. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02876.x · Cited by 335
Wierckx, K., Elaut, E., Declercq, E., Heylens, G., De Cuypere, G., Taes, Y., Kaufman, J. M., & T'Sjoen, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0493 · Cited by 329
Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A., Toye, K., Kaufman, J. M., & T'Sjoen, G. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12571 · Cited by 316
Wylie, K., Knudson, G., Khan, S. I., Bonierbale, M., Watanyusakul, S., & Baral, S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00682-6 · Cited by 316
Integrated and Gender-Affirming Transgender Clinical Care and Research
Reisner, S. L., Radix, A., & Deutsch, M. B. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001088 · Cited by 311
Barriers to quality health care for the transgender population
Roberts, T. K., & Fantz, C. R. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.02.009 · Cited by 298
The State of Transgender Health Care: Policy, Law, and Medical Frameworks
Stroumsa, D. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301789 · Cited by 297
Low Fertility Preservation Utilization Among Transgender Youth
Nahata, L., Tishelman, A. C., Caltabellotta, N. M., & Quinn, G. P. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.12.012 · Cited by 287
Testosterone therapy for transgender men
Irwig, M. S. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00036-x · Cited by 272
Bauer, G. R., Scheim, A. I., Deutsch, M. B., & Massarella, C. (2014) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2013.09.027 · Cited by 265
Reisner, S. L., White Hughto, J. M., Gamarel, K. E., Keuroghlian, A. S., Mizock, L., & Pachankis, J. E. (2016) · Journal of Counseling Psychology · doi:10.1037/cou0000143 · Cited by 262
Adelson, S. L. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.07.004 · Cited by 254
Obedin-Maliver, J., & Makadon, H. J. (2016) · Obstetric Medicine · doi:10.1177/1753495x15612658 · Cited by 252
“For those who elect to use testosterone, its use may affect fertility, fecundity, and impact fetal development.(16,29,30) Unfortunately, there is little data to inform balanced conversations on the topic.”
BackgroundHormone therapy for transgender patients
Unger, C. A. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.09.04 · Cited by 245
“As a result, there are strong recommendations against the use of ethinyl estradiol in transgender patients (8).”
BackgroundInfluentialMacDonald, T., Noel-Weiss, J., West, D., Walks, M., Biener, M., Kibbe, A., & Myler, E. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-0907-y · Cited by 225
Peterson, C. M., Matthews, A., Copps‐Smith, E., & Conard, L. A. (2017) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12289 · Cited by 219
Characteristics of Referrals for Gender Dysphoria Over a 13-Year Period
Chen, M., Fuqua, J., & Eugster, E. A. (2016) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2015.11.010 · Cited by 209
“Despite the availability of practice guidelines [2,3], most of our patients are referred before a GD-specific psychological evaluation.”
Cancer in Transgender People: Evidence and Methodological Considerations
Braun, H., Nash, R., Tangpricha, V., Brockman, J., Ward, K., & Goodman, M. (2017) · Epidemiologic Reviews · doi:10.1093/epirev/mxw003 · Cited by 208
“This lack of high-quality data is acknowledged in the current guidelines issued by various professional organizations (7, 120, 122).”
BackgroundSelf-citationOestrogen and anti-androgen therapy for transgender women
Tangpricha, V., & den Heijer, M. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30319-9 · Cited by 207
Self-citationClinical Management of Youth with Gender Dysphoria in Vancouver
Khatchadourian, K., Amed, S., & Metzger, D. L. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.10.068 · Cited by 195
Effects of Three Different Testosterone Formulations in Female-to-Male Transsexual Persons
Pelusi, C., Costantino, A., Martelli, V., Lambertini, M., Bazzocchi, A., Ponti, F., Battista, G., Venturoli, S., & Meriggiola, M. C. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12698 · Cited by 181
Turban, J. L., King, D., Kobe, J., Reisner, S. L., & Keuroghlian, A. S. (2022) · PLOS ONE · doi:10.1371/journal.pone.0261039 · Cited by 180
“The third group consisted of participants who reported they first accessed GAH during late PLOS ONE | https://doi.org/10.1371/journal.pone.0261039 January 12, 2022 3 / 15 adolescence, defined as the period between their 16th and 18th birthdays (GAH 16–17), corresponding to the narrower age group in the prior, 2009 End…”
BackgroundInfluentialWeinand, J. D., & Safer, J. D. (2015) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2015.02.003 · Cited by 175
Puberty suppression in gender identity disorder: the Amsterdam experience
Kreukels, B. P. C., & Cohen-Kettenis, P. T. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.78 · Cited by 173
“Hormone treatment guidelines have been formulated by the Endocrine Society”
BackgroundSelf-citationResearch Review: Gender identity in youth: treatment paradigms and controversies
Turban, J. L., & Ehrensaft, D. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12833 · Cited by 170
“…options Surgical interventions are generally reserved for transgender individuals who have reached the age of adulthood (Coleman et al., 2011; Hembree et al., 2009), although, based on the stages versus ages model, surgical procedures are increasingly being offered to older youth prior to…”
BackgroundMethodVelho, I., Fighera, T. M., Ziegelmann, P. K., & Spritzer, P. M. (2017) · Andrology · doi:10.1111/andr.12382 · Cited by 160
“Indeed, the goal of cross-sex hormone treatment for transgender men should be to achieve equal or slightly lower male physiological levels of serum testosterone to maintain adequate androgenization (Hembree et al., 2009; Traish & Gooren, 2010; Meriggiola & Gava, 2015).”
BackgroundApproach to the Patient: Transgender Youth: Endocrine Considerations
Rosenthal, S. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1919 · Cited by 159
“S P E C I A L F E A T U R E A p p r o a c h t o t h e P a t i e n t doi: 10.1210/jc.2014-1919 J Clin Endocrinol Metab, December 2014, 99(12):4379–4389 jcem.endojournals.org 4379 The Endocrine Society.”
BackgroundMethodInfluentialOlson-Kennedy, J., Cohen-Kettenis, P. T., Kreukels, B. P. C., Meyer-Bahlburg, H. F. L., Garofalo, R., Meyer, W., & Rosenthal, S. M. (2016) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000236 · Cited by 158
Self-citationRew, L., Young, C. C., Monge, M., & Bogucka, R. (2021) · Child and Adolescent Mental Health · doi:10.1111/camh.12437 · Cited by 139
Gender incongruence of childhood in the ICD-11: controversies, proposal, and rationale
Drescher, J., Cohen-Kettenis, P. T., & Reed, G. M. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00586-6 · Cited by 133
Self-citationVrouenraets, L. J. J. J., Fredriks, A. M., Hannema, S. E., Cohen-Kettenis, P. T., & de Vries, M. C. (2015) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2015.04.004 · Cited by 127
“Previous presentations: oral presentation during the 2014 World Professional Association for Transgender Health Congress in Bangkok, Thailand (February 2014); poster presentation during the Endocrine Society Congress in Chicago, the United States (June 2014); oral presentation during the World Congress of Bioethics in…”
BackgroundInfluentialSelf-citationCross-Sex Hormones and Metabolic Parameters in Adolescents With Gender Dysphoria
Jarin, J., Pine-Twaddell, E., Trotman, G., Stevens, J., Conard, L. A., Tefera, E., & Gomez-Lobo, V. (2017) · Pediatrics · doi:10.1542/peds.2016-3173 · Cited by 119
Interpreting Laboratory Results in Transgender Patients on Hormone Therapy
Roberts, T. K., Kraft, C. S., French, D., Ji, W., Wu, A. H. B., Tangpricha, V., & Fantz, C. R. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.10.009 · Cited by 109
Self-citationAndrogens and endometrium: new insights and new targets
Simitsidellis, I., Saunders, P. T. K., & Gibson, D. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.022 · Cited by 107
Fisher, A. D., Ristori, J., Fanni, E., Castellini, G., Forti, G., & Maggi, M. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0482-0 · Cited by 100
Impact of Hormone Therapy on Laboratory Values in Transgender Patients
SoRelle, J. A., Jiao, R., Gao, E., Veazey, J., Frame, I., Quinn, A. M., Day, P., Pagels, P., Gimpel, N., & Patel, K. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.292730 · Cited by 86
Gava, G., Cerpolini, S., Martelli, V., Battista, G., Seracchioli, R., & Meriggiola, M. C. (2016) · Clinical Endocrinology · doi:10.1111/cen.13050 · Cited by 83
Auer, M. K., Ebert, T., Pietzner, M., Defreyne, J., Fuss, J., Stalla, G. K., & T’Sjoen, G. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01559 · Cited by 75
Anorexia nervosa and gender dysphoria in two adolescents
Couturier, J., Pindiprolu, B., Findlay, S., & Johnson, N. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22368 · Cited by 74
Jacobeit, J. W., Gooren, L. J., & Schulte, H. M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0412 · Cited by 73
Self-citationPrimary sigmoid vaginoplasty in transwomen: technique and outcomes.
Salgado, C. J., Nugent, A., Kuhn, J., Janette, M., & Bahna, H. (2018) · BioMed Research International · doi:10.1155/2018/4907208 · Cited by 64
“However, there are no tests to monitor synthetic estrogens and no evidence that establishes a risk optimization protocol in transwomen [29, 30, 34].”
BackgroundTack, L. J. W., Heyse, R., Craen, M., Dhondt, K., Bossche, H. V., Laridaen, J., & Cools, M. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.03.251 · Cited by 52
“Criteria to start CSH therapy were based on the Endocrine Society guidelines.(18) All adolescents were prescribed vitamin D supplementation and a calcium-enriched diet during treatment.”
MethodAssociation of Spironolactone Use With Risk of Cancer: A Systematic Review and Meta-analysis
Bommareddy, K., Hamade, H., Lopez-Olivo, M. A., Wehner, M., Tosh, T., & Barbieri, J. S. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.5866 · Cited by 49
Altered arterial stiffness in male-to-female transsexuals undergoing hormonal treatment
Sharula, Chekir, C., Emi, Y., Arai, F., Kikuchi, Y., Sasaki, A., Matsuda, M., Shimizu, K., Tabuchi, K., Kamada, Y., et al. (2012) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2011.01815.x · Cited by 24
“The largest cohort of MTF subjects followed for a mean of 10 years showed no increase in cardiovascular mortality.(19) Furthermore, current ethinyl estradiol use was associated with an independent threefold increased risk of cardiovascular death.”
BackgroundInfluentialMandal, E., & Jakubowski, T. (2015) · Archives of Psychiatry and Psychotherapy · doi:10.12740/app/58746 · Cited by 4
“However, the particular mechanism that determines future gender dysphoria is still unknown, and the prenatal androgenization – gender dysphoria association was observed in transsexual women (biological males who identify as females), but not in transmen (biological females who identify as males) [4].”
Metadata
- Authors
- Hembree, W. C., Cohen-Kettenis, P., Delemarre-van de Waal, H. A., Gooren, L. J., Meyer, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-09-01
- Volume
- 94
- Issue
- 9
- Pages
- 3132-3154
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2148911925
- Cited by
- 1,026
- References
- 163
- FWCI
- 42.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.